0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetic Retinopathy Screening Solution Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-19Y18095
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetic Retinopathy Screening Solution Market Research Report 2024
BUY CHAPTERS

Global Diabetic Retinopathy Screening Solution Market Research Report 2026

Code: QYRE-Auto-19Y18095
Report
2026-02-11
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diabetic Retinopathy Screening Solution Market

The global Diabetic Retinopathy Screening Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Diabetic retinopathy screening solution is a medical technology solution used to detect and evaluate the retinal health status of diabetic patients. It usually includes retinal imaging, image analysis, lesion detection and diagnostic report generation, aiming to detect diabetic retinopathy early, so as to provide timely treatment and management and prevent vision loss.
The North American market for Diabetic Retinopathy Screening Solution is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Diabetic Retinopathy Screening Solution is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Diabetic Retinopathy Screening Solution in Medical Industry is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Diabetic Retinopathy Screening Solution include RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk, Thirona Retina, Synapxe, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Diabetic Retinopathy Screening Solution market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Diabetic Retinopathy Screening Solution. The Diabetic Retinopathy Screening Solution market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Diabetic Retinopathy Screening Solution market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Diabetic Retinopathy Screening Solution manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Diabetic Retinopathy Screening Solution Market Report

Report Metric Details
Report Name Diabetic Retinopathy Screening Solution Market
Segment by Type
  • Traditional
  • Artificial Intelligence
  • Others
Segment by Application
  • Medical Industry
  • Scientific Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk, Thirona Retina, Synapxe, Eyenuk, EyRIS (SELENA+), Vistel
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Diabetic Retinopathy Screening Solution companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Diabetic Retinopathy Screening Solution Market report?

Ans: The main players in the Diabetic Retinopathy Screening Solution Market are RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk, Thirona Retina, Synapxe, Eyenuk, EyRIS (SELENA+), Vistel

What are the Application segmentation covered in the Diabetic Retinopathy Screening Solution Market report?

Ans: The Applications covered in the Diabetic Retinopathy Screening Solution Market report are Medical Industry, Scientific Research, Others

What are the Type segmentation covered in the Diabetic Retinopathy Screening Solution Market report?

Ans: The Types covered in the Diabetic Retinopathy Screening Solution Market report are Traditional, Artificial Intelligence, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Traditional
1.2.3 Artificial Intelligence
1.2.4 Others
1.3 Market by Application
1.3.1 Global Diabetic Retinopathy Screening Solution Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy Screening Solution Market Perspective (2021–2032)
2.2 Global Diabetic Retinopathy Screening Solution Growth Trends by Region
2.2.1 Global Diabetic Retinopathy Screening Solution Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Diabetic Retinopathy Screening Solution Historic Market Size by Region (2021–2026)
2.2.3 Diabetic Retinopathy Screening Solution Forecasted Market Size by Region (2027–2032)
2.3 Diabetic Retinopathy Screening Solution Market Dynamics
2.3.1 Diabetic Retinopathy Screening Solution Industry Trends
2.3.2 Diabetic Retinopathy Screening Solution Market Drivers
2.3.3 Diabetic Retinopathy Screening Solution Market Challenges
2.3.4 Diabetic Retinopathy Screening Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy Screening Solution Players by Revenue
3.1.1 Global Top Diabetic Retinopathy Screening Solution Players by Revenue (2021–2026)
3.1.2 Global Diabetic Retinopathy Screening Solution Revenue Market Share by Players (2021–2026)
3.2 Global Top Diabetic Retinopathy Screening Solution Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Diabetic Retinopathy Screening Solution Revenue
3.4 Global Diabetic Retinopathy Screening Solution Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy Screening Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Screening Solution Revenue in 2025
3.5 Global Key Players of Diabetic Retinopathy Screening Solution Head Offices and Areas Served
3.6 Global Key Players of Diabetic Retinopathy Screening Solution, Products and Applications
3.7 Global Key Players of Diabetic Retinopathy Screening Solution, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Diabetic Retinopathy Screening Solution Breakdown Data by Type
4.1 Global Diabetic Retinopathy Screening Solution Historic Market Size by Type (2021–2026)
4.2 Global Diabetic Retinopathy Screening Solution Forecasted Market Size by Type (2027–2032)
5 Diabetic Retinopathy Screening Solution Breakdown Data by Application
5.1 Global Diabetic Retinopathy Screening Solution Historic Market Size by Application (2021–2026)
5.2 Global Diabetic Retinopathy Screening Solution Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Diabetic Retinopathy Screening Solution Market Size (2021–2032)
6.2 North America Diabetic Retinopathy Screening Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Diabetic Retinopathy Screening Solution Market Size by Country (2021–2026)
6.4 North America Diabetic Retinopathy Screening Solution Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Retinopathy Screening Solution Market Size (2021–2032)
7.2 Europe Diabetic Retinopathy Screening Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2021–2026)
7.4 Europe Diabetic Retinopathy Screening Solution Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size (2021–2032)
8.2 Asia-Pacific Diabetic Retinopathy Screening Solution Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size by Region (2021–2026)
8.4 Asia-Pacific Diabetic Retinopathy Screening Solution Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Diabetic Retinopathy Screening Solution Market Size (2021–2032)
9.2 Latin America Diabetic Retinopathy Screening Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Diabetic Retinopathy Screening Solution Market Size by Country (2021–2026)
9.4 Latin America Diabetic Retinopathy Screening Solution Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size (2021–2032)
10.2 Middle East & Africa Diabetic Retinopathy Screening Solution Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2021–2026)
10.4 Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RETINA-AI Health
11.1.1 RETINA-AI Health Company Details
11.1.2 RETINA-AI Health Business Overview
11.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Introduction
11.1.4 RETINA-AI Health Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.1.5 RETINA-AI Health Recent Development
11.2 IRIS
11.2.1 IRIS Company Details
11.2.2 IRIS Business Overview
11.2.3 IRIS Diabetic Retinopathy Screening Solution Introduction
11.2.4 IRIS Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.2.5 IRIS Recent Development
11.3 Retina Labs
11.3.1 Retina Labs Company Details
11.3.2 Retina Labs Business Overview
11.3.3 Retina Labs Diabetic Retinopathy Screening Solution Introduction
11.3.4 Retina Labs Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.3.5 Retina Labs Recent Development
11.4 CheckEye
11.4.1 CheckEye Company Details
11.4.2 CheckEye Business Overview
11.4.3 CheckEye Diabetic Retinopathy Screening Solution Introduction
11.4.4 CheckEye Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.4.5 CheckEye Recent Development
11.5 RetinaLyze
11.5.1 RetinaLyze Company Details
11.5.2 RetinaLyze Business Overview
11.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Introduction
11.5.4 RetinaLyze Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.5.5 RetinaLyze Recent Development
11.6 NEC Software
11.6.1 NEC Software Company Details
11.6.2 NEC Software Business Overview
11.6.3 NEC Software Diabetic Retinopathy Screening Solution Introduction
11.6.4 NEC Software Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.6.5 NEC Software Recent Development
11.7 InHealth Intelligence
11.7.1 InHealth Intelligence Company Details
11.7.2 InHealth Intelligence Business Overview
11.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Introduction
11.7.4 InHealth Intelligence Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.7.5 InHealth Intelligence Recent Development
11.8 RetinaRisk
11.8.1 RetinaRisk Company Details
11.8.2 RetinaRisk Business Overview
11.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Introduction
11.8.4 RetinaRisk Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.8.5 RetinaRisk Recent Development
11.9 Thirona Retina
11.9.1 Thirona Retina Company Details
11.9.2 Thirona Retina Business Overview
11.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Introduction
11.9.4 Thirona Retina Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.9.5 Thirona Retina Recent Development
11.10 Synapxe
11.10.1 Synapxe Company Details
11.10.2 Synapxe Business Overview
11.10.3 Synapxe Diabetic Retinopathy Screening Solution Introduction
11.10.4 Synapxe Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.10.5 Synapxe Recent Development
11.11 Eyenuk
11.11.1 Eyenuk Company Details
11.11.2 Eyenuk Business Overview
11.11.3 Eyenuk Diabetic Retinopathy Screening Solution Introduction
11.11.4 Eyenuk Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.11.5 Eyenuk Recent Development
11.12 EyRIS (SELENA+)
11.12.1 EyRIS (SELENA+) Company Details
11.12.2 EyRIS (SELENA+) Business Overview
11.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Introduction
11.12.4 EyRIS (SELENA+) Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.12.5 EyRIS (SELENA+) Recent Development
11.13 Vistel
11.13.1 Vistel Company Details
11.13.2 Vistel Business Overview
11.13.3 Vistel Diabetic Retinopathy Screening Solution Introduction
11.13.4 Vistel Revenue in Diabetic Retinopathy Screening Solution Business (2021–2026)
11.13.5 Vistel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Traditional
 Table 3. Key Players of Artificial Intelligence
 Table 4. Key Players of Others
 Table 5. Global Diabetic Retinopathy Screening Solution Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Diabetic Retinopathy Screening Solution Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Diabetic Retinopathy Screening Solution Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Diabetic Retinopathy Screening Solution Market Share by Region (2021–2026)
 Table 9. Global Diabetic Retinopathy Screening Solution Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Diabetic Retinopathy Screening Solution Market Share by Region (2027–2032)
 Table 11. Diabetic Retinopathy Screening Solution Market Trends
 Table 12. Diabetic Retinopathy Screening Solution Market Drivers
 Table 13. Diabetic Retinopathy Screening Solution Market Challenges
 Table 14. Diabetic Retinopathy Screening Solution Market Restraints
 Table 15. Global Diabetic Retinopathy Screening Solution Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Diabetic Retinopathy Screening Solution Market Share by Players (2021–2026)
 Table 17. Global Top Diabetic Retinopathy Screening Solution Players by Tier (Tier 1, Tier 2, and Tier 3), based on Diabetic Retinopathy Screening Solution Revenue, 2025
 Table 18. Ranking of Global Top Diabetic Retinopathy Screening Solution Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Diabetic Retinopathy Screening Solution Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Diabetic Retinopathy Screening Solution, Headquarters and Area Served
 Table 21. Global Key Players of Diabetic Retinopathy Screening Solution, Products and Applications
 Table 22. Global Key Players of Diabetic Retinopathy Screening Solution, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Diabetic Retinopathy Screening Solution Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2021–2026)
 Table 26. Global Diabetic Retinopathy Screening Solution Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2027–2032)
 Table 28. Global Diabetic Retinopathy Screening Solution Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2021–2026)
 Table 30. Global Diabetic Retinopathy Screening Solution Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2027–2032)
 Table 32. North America Diabetic Retinopathy Screening Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Diabetic Retinopathy Screening Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Diabetic Retinopathy Screening Solution Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Diabetic Retinopathy Screening Solution Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Diabetic Retinopathy Screening Solution Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Diabetic Retinopathy Screening Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Diabetic Retinopathy Screening Solution Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Diabetic Retinopathy Screening Solution Market Size by Country (US$ Million), 2027–2032
 Table 47. RETINA-AI Health Company Details
 Table 48. RETINA-AI Health Business Overview
 Table 49. RETINA-AI Health Diabetic Retinopathy Screening Solution Product
 Table 50. RETINA-AI Health Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 51. RETINA-AI Health Recent Development
 Table 52. IRIS Company Details
 Table 53. IRIS Business Overview
 Table 54. IRIS Diabetic Retinopathy Screening Solution Product
 Table 55. IRIS Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 56. IRIS Recent Development
 Table 57. Retina Labs Company Details
 Table 58. Retina Labs Business Overview
 Table 59. Retina Labs Diabetic Retinopathy Screening Solution Product
 Table 60. Retina Labs Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 61. Retina Labs Recent Development
 Table 62. CheckEye Company Details
 Table 63. CheckEye Business Overview
 Table 64. CheckEye Diabetic Retinopathy Screening Solution Product
 Table 65. CheckEye Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 66. CheckEye Recent Development
 Table 67. RetinaLyze Company Details
 Table 68. RetinaLyze Business Overview
 Table 69. RetinaLyze Diabetic Retinopathy Screening Solution Product
 Table 70. RetinaLyze Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 71. RetinaLyze Recent Development
 Table 72. NEC Software Company Details
 Table 73. NEC Software Business Overview
 Table 74. NEC Software Diabetic Retinopathy Screening Solution Product
 Table 75. NEC Software Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 76. NEC Software Recent Development
 Table 77. InHealth Intelligence Company Details
 Table 78. InHealth Intelligence Business Overview
 Table 79. InHealth Intelligence Diabetic Retinopathy Screening Solution Product
 Table 80. InHealth Intelligence Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 81. InHealth Intelligence Recent Development
 Table 82. RetinaRisk Company Details
 Table 83. RetinaRisk Business Overview
 Table 84. RetinaRisk Diabetic Retinopathy Screening Solution Product
 Table 85. RetinaRisk Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 86. RetinaRisk Recent Development
 Table 87. Thirona Retina Company Details
 Table 88. Thirona Retina Business Overview
 Table 89. Thirona Retina Diabetic Retinopathy Screening Solution Product
 Table 90. Thirona Retina Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 91. Thirona Retina Recent Development
 Table 92. Synapxe Company Details
 Table 93. Synapxe Business Overview
 Table 94. Synapxe Diabetic Retinopathy Screening Solution Product
 Table 95. Synapxe Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 96. Synapxe Recent Development
 Table 97. Eyenuk Company Details
 Table 98. Eyenuk Business Overview
 Table 99. Eyenuk Diabetic Retinopathy Screening Solution Product
 Table 100. Eyenuk Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 101. Eyenuk Recent Development
 Table 102. EyRIS (SELENA+) Company Details
 Table 103. EyRIS (SELENA+) Business Overview
 Table 104. EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product
 Table 105. EyRIS (SELENA+) Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 106. EyRIS (SELENA+) Recent Development
 Table 107. Vistel Company Details
 Table 108. Vistel Business Overview
 Table 109. Vistel Diabetic Retinopathy Screening Solution Product
 Table 110. Vistel Revenue in Diabetic Retinopathy Screening Solution Business (US$ Million), 2021–2026
 Table 111. Vistel Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Diabetic Retinopathy Screening Solution Picture
 Figure 2. Global Diabetic Retinopathy Screening Solution Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Diabetic Retinopathy Screening Solution Market Share by Type: 2025 vs 2032
 Figure 4. Traditional Features
 Figure 5. Artificial Intelligence Features
 Figure 6. Others Features
 Figure 7. Global Diabetic Retinopathy Screening Solution Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Diabetic Retinopathy Screening Solution Market Share by Application: 2025 vs 2032
 Figure 9. Medical Industry Case Studies
 Figure 10. Scientific Research Case Studies
 Figure 11. Others Case Studies
 Figure 12. Diabetic Retinopathy Screening Solution Report Years Considered
 Figure 13. Global Diabetic Retinopathy Screening Solution Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Diabetic Retinopathy Screening Solution Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Diabetic Retinopathy Screening Solution Market Share by Region: 2025 vs 2032
 Figure 16. Global Diabetic Retinopathy Screening Solution Market Share by Players in 2025
 Figure 17. Global Diabetic Retinopathy Screening Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Screening Solution Revenue in 2025
 Figure 19. North America Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Diabetic Retinopathy Screening Solution Market Share by Country (2021–2032)
 Figure 21. United States Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Diabetic Retinopathy Screening Solution Market Share by Country (2021–2032)
 Figure 25. Germany Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Diabetic Retinopathy Screening Solution Market Share by Region (2021–2032)
 Figure 33. China Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Diabetic Retinopathy Screening Solution Market Share by Country (2021–2032)
 Figure 41. Mexico Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Diabetic Retinopathy Screening Solution Market Share by Country (2021–2032)
 Figure 45. Israel Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Diabetic Retinopathy Screening Solution Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. RETINA-AI Health Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 49. IRIS Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 50. Retina Labs Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 51. CheckEye Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 52. RetinaLyze Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 53. NEC Software Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 54. InHealth Intelligence Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 55. RetinaRisk Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 56. Thirona Retina Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 57. Synapxe Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 58. Eyenuk Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 59. EyRIS (SELENA+) Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 60. Vistel Revenue Growth Rate in Diabetic Retinopathy Screening Solution Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS